The 12 closest competitors and alternatives to CircNova among healthcare companies — ranked by similarity to what CircNova actually does, not by market-cap band.
Subscribe to see CircNova’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CircNova is a private biotechnology company founded in 2023 with headquarters in Detroit, Michigan, specializing in the development of RNA-based therapeutics.
CircNova is a healthcare company headquartered in United States. Its most recent funding round, Seed, raised $3.3M in February 2025. Xcout tracks 6 named people at CircNova, including Cindy Warner (Chief Operating Officer).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $3.3M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to CircNova by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar healthcare company
GEMMABio is a privately held therapeutics company founded in 2024 in Philadelphia, Pennsylvania, dedicated to developing novel gene therapies for rare diseases.
Similar healthcare company
Juvena Therapeutics, Inc. is a computationally-driven biopharmaceutical company operating in the biotechnology and biopharma industry, headquartered in Redwood City, California.
Similar healthcare company
Ractigen Therapeutics is a clinical-stage biopharmaceutical company headquartered in China that specializes in pioneering siRNA therapies designed to silence target genes.
Similar healthcare company
Full Circles Therapeutics Inc. is a biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on therapeutic innovations and engages in in vivo cell research collaborations.
Similar healthcare company
Ailomics Therapeutics, founded in 2022 and headquartered in Shanghai, China, is a therapeutics company focused on discovering novel targets.
Biotechnology
RNAV8 Bio is a biotechnology research company focused on renovating mRNA function through structure, chemistry, and delivery.
Biotech
CiRC Biosciences is a privately held regenerative medicine and cell therapy company founded in 2019 and based in Chicago, Illinois, focused on developing cellular reprogramming solutions for degenerative diseases.
Biotechnology
ResNovas Therapeutics is a biotechnology and therapeutics company headquartered in Alameda, California, operating within the San Francisco Bay Area.
Biotech
Nosis Biosciences develops receptor-targeted RNA medicines utilizing its proprietary AI-powered platform, Connexa, which combines physics-aware deep learning, single cell biology, and high-throughput chemistry. The company's platform designs gene-silencing therapeutics intended to treat chronic conditions across various cell types and organ systems, including the heart, lungs, kidneys, and brain.
Life Sciences (Therapeutics)
DTx Pharma, Inc. is a privately held biotechnology company based in San Diego, California, that addresses the challenges associated with delivering RNA-based therapeutics.
Biotechnology
Ceptur Therapeutics, Inc. is a private biotechnology company headquartered in Hillsborough, New Jersey, focused on developing targeted oligonucleotide therapeutics.
Biotechnology
ONL Therapeutics, Inc. is a clinical-stage biopharmaceutical company located in Michigan, United States, focused on the development of novel therapies for retinal diseases.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CircNovaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →